A Multi-Site Trial of MS INFoRm (Fatigue Management Resource)
NCT ID: NCT03362541
Last Updated: 2022-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
161 participants
INTERVENTIONAL
2018-01-30
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To determine to determine whether 3-month use of the MS INFoRm website can reduce the impact of fatigue on daily life among persons with MS.
2. To determine whether 3-month use of the MS INFoRm website results in improvement in self- efficacy/ confidence for managing MS fatigue, self-reported cognitive function, participation and autonomy/ independence, and depression.
3. To determine whether benefits are maintained among the MS INFoRm users after 6-months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fatigue Management Programs for People With MS
NCT03550170
Pilot Study for the Evaluation of the More Stamina in Persons With Multiple Sclerosis
NCT04244214
Teleconference Fatigue Management for People With Multiple Sclerosis
NCT00591721
Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue
NCT03621761
Examining the Effects of a Telehealth Self-management Intervention in Multiple Sclerosis
NCT01572714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MS INFoRm group
Participants in the MS INFoRm group will be given a login and password that will take them to the MS INFoRm webpage. Access will be granted for 3-months, starting on the date of the first login. Participants can access the website at any time, at their own volition over the 3-months.
MS INFoRm
MS INFoRm incorporates principles of self-management and adult learning theory. The contents address the sources of fatigue, ways of monitoring fatigue, and strategies to reduce fatigue.
Usual care control group
Participants in the usual care group will be given a login and password that will take them to a usual care webpage. Access will be granted for 3-months, starting on the date of the first login. Participants can access the website at any time, at their own volition over the 3-months.
Usual Care Control Group
The usual care webpage will contain content from widely available resources about MS fatigue.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MS INFoRm
MS INFoRm incorporates principles of self-management and adult learning theory. The contents address the sources of fatigue, ways of monitoring fatigue, and strategies to reduce fatigue.
Usual Care Control Group
The usual care webpage will contain content from widely available resources about MS fatigue.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between 18 and 65 years of age
* access to a computer or other electronic device with internet access on which to use the website
* report mild to moderate fatigue
* live in Canada
Exclusion Criteria
* report difficulty reading and comprehending English written at a Grade 7 level
* report upper extremity or visual impairments that cannot be accommodated adequately to enable computer access
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alberta
OTHER
University of Calgary
OTHER
Dr. Marcia Finlayson
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Marcia Finlayson
Vice Dean Health Sciences, Director School of Rehabilitation Therapy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcia Finlayson, PhD
Role: PRINCIPAL_INVESTIGATOR
Queen's University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Calgary
Calgary, Alberta, Canada
University of Alberta
Edmonton, Alberta, Canada
Queen's University
Kingston, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Finlayson M, Akbar N, Turpin K, Smyth P. A multi-site, randomized controlled trial of MS INFoRm, a fatigue self-management website for persons with multiple sclerosis: rationale and study protocol. BMC Neurol. 2019 Jun 25;19(1):142. doi: 10.1186/s12883-019-1367-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6020674
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.